A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tadalafil
Ethyl loflazepate
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Ethyl loflazepate.
Tadalafil
Flunitrazepam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Flunitrazepam.
Tadalafil
Carfentanil
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Carfentanil.
Tadalafil
Chlorhexadol
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Chlorhexadol.
Tadalafil
Desomorphine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Desomorphine.
Tadalafil
Dextromoramide
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Dextromoramide.
Tadalafil
Delorazepam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Delorazepam.
Tadalafil
Tenamfetamine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Tenamfetamine.
Tadalafil
Difenoxin
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Difenoxin.
Tadalafil
Etorphine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Etorphine.
Tadalafil
Dichloralphenazone
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Dichloralphenazone.
Tadalafil
Camazepam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Camazepam.
Tadalafil
Dimethyltryptamine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Dimethyltryptamine.
Tadalafil
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with 4-Bromo-2,5-dimethoxyamphetamine.
Tadalafil
Barbital
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Barbital.
Tadalafil
4-Methoxyamphetamine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with 4-Methoxyamphetamine.
Tadalafil
Ethylmorphine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Ethylmorphine.
Tadalafil
Fencamfamin
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Fencamfamin.
Tadalafil
Midomafetamine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Midomafetamine.
Tadalafil
Diamorphine
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Diamorphine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3